Predicative values of C‑reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure

Wang,Yinjia; Li,Li

doi:10.3892/etm.2018.6577

Predicative values of C‑reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure

Authors:
- Yinjia Wang
- Li Li
View Affiliations

Affiliations: Intensive Care Unit, The First People's Hospital of Kunming, Kunming, Yunnan 650224, P.R. China
Published online on: August 7, 2018 https://doi.org/10.3892/etm.2018.6577
Pages: 3165-3171

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Severe acute pancreatitis (SAP) is a serious systemic disease with high mortality. Ulinastatin is a drug widely used for patients with SAP and multiple organ failure syndrome. The present study aimed to investigate the capacity of the serum C‑reactive protein (CRP) levels to predict the therapeutic effects of ulinastatin combined with somatostatin as well as determine the severity of SAP. SAP patients were treated with ulinastatin combined with somatostatin and serum CRP levels were measured. The computed tomography severity index (CTSI), acute physiology and chronic health evaluation II (APACHE II) and gastrointestinal failure scores were used to determine the therapeutic effects. All patients were assigned to the effective group and the ineffective group. Receiver operating characteristic curve analysis was performed to determine the sensitivity and specificity of CRP levels in predicting the severity of SAP and patient prognosis. Logistic regression analysis was adopted to investigate the factors influencing the therapeutic effects. Prior to and after treatment, serum CRP levels in patients of the effective and ineffective groups were significantly different. After treatment, serum CRP levels in patients of the effective group exhibited a more obvious reduction. The sensitivity and specificity of serum CRP levels in predicting the therapeutic effects of ulinastatin combined with somatostatin in SAP patients upon hospital admission were 0.813 and 0.934, respectively. Serum CRP levels were positively correlated with APACHE II, CTSI and gastrointestinal failure scores of SAP patients. The logistic regression demonstrated that serum albumin, creatinine and CRP levels on admission were factors influencing the therapeutic effects of ulinastatin combined with somatostatin in SAP patients. These results indicate that serum CRP levels may have a predictive value regarding the therapeutic effects of ulinastatin combined with somatostatin and are an indicator of the severity of gastrointestinal failure in SAP.

View Figures

View References

1	Türkvatan A, Erden A, Türkoğlu MA, Seçil M and Yener Ö: Imaging of acute pancreatitis and its complications. Part 1 Acute pancreatitis. Diagn Interv Imaging. 96:151–160. 2015. View Article : Google Scholar
2	Kuramatsu JB, Huttner HB and Schwab S: Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna). 120 Suppl 1:S35–S41. 2013. View Article : Google Scholar : PubMed/NCBI
3	Yadav D and Lowenfels AB: The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
4	Maheshwari R and Subramanian RM: Severe acute pancreatitis and necrotizing pancreatitis. Crit Care Clin. 32:279–290. 2016. View Article : Google Scholar : PubMed/NCBI
5	Yang ZW, Meng XX and Xu P: Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med. 19:2513–2520. 2015. View Article : Google Scholar : PubMed/NCBI
6	Sternby H, Hartman H, Johansen D, Thorlacius H and Regner S: Predictive capacity of biomarkers for severe acute pancreatitis. Eur Surg Res. 56:154–163. 2016. View Article : Google Scholar : PubMed/NCBI
7	Liu R, Qi H, Wang J, Wang Y, Cui L, Wen Y and Yin C: Ulinastatin activates the renin-angiotensin system to ameliorate the pathophysiology of severe acute pancreatitis. J Gastroenterol Hepatol. 29:1328–1337. 2014. View Article : Google Scholar : PubMed/NCBI
8	Chen S, Shi H, Zou X and Luo H: Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: The Emperor's new clothes or aladdin's magic lamp? Pancreas. 39:1231–1237. 2010. View Article : Google Scholar : PubMed/NCBI
9	Jia R, Tang M, Qiu L, Sun R, Cheng L, Ma X, Yin G, Hu G, Wang X and Zhao Y: Increased interleukin-23/17 axis and C-reactive protein are associated with severity of acute pancreatitis in patients. Pancreas. 44:321–325. 2015. View Article : Google Scholar : PubMed/NCBI
10	Gurleyik G, Emir S, Kilicoglu G, Arman A and Saglam A: Computed tomography severity index, APACHE II score, and serum CRP concentration for predicting the severity of acute pancreatitis. JOP. 6:562–567. 2005.PubMed/NCBI
11	Ansar W and Ghosh S: C-reactive protein and the biology of disease. Immunol Res. 56:131–142. 2013. View Article : Google Scholar : PubMed/NCBI
12	Allin KH and Nordestgaard BG: Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 48:155–170. 2011. View Article : Google Scholar : PubMed/NCBI
13	Singh PP, Zeng IS, Srinivasa S, Lemanu DP, Connolly AB and Hill AG: Systematic review and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. Br J Surg. 101:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
14	Sato T, Ohno K, Tamamoto T, Oishi M, Kanemoto H, Fukushima K, Goto-Koshino Y, Takahashi M and Tsujimoto H: Assesment of severity and changes in C-reactive protein concentration and various biomarkers in dogs with pancreatitis. J Vet Med Sci. 79:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
15	Tachyla SA, Marochkov AV, Lipnitski AL and Nikiforova YG: The prognostic value of procalcitonin, C-reactive protein and cholesterol in patients with an infection and multiple organ dysfunction. Korean J Anesthesiol. 70:305–310. 2017. View Article : Google Scholar : PubMed/NCBI
16	Pongprasobchai S, Jianjaroonwong V, Charatcharoenwitthaya P, Komoltri C, Tanwandee T, Leelakusolvong S, Pausawasdi N, Srikureja W, Chainuvati S, Prachayakul V, et al: Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis. Pancreas. 39:1226–1230. 2010. View Article : Google Scholar : PubMed/NCBI
17	Loveday BP, Srinivasa S, Vather R, Mittal A, Petrov MS, Phillips AR and Windsor JA: High quantity and variable quality of guidelines for acute pancreatitis: A systematic review. Am J Gastroenterol. 105:1466–1476. 2010. View Article : Google Scholar : PubMed/NCBI
18	Tsuji Y, Takahashi N and Tsutomu C: Pancreatic perfusion CT in early stage of severe acute pancreatitis. Int J Inflam. 2012:4973862012. View Article : Google Scholar : PubMed/NCBI
19	Reintam A, Parm P, Kitus R, Starkopf J and Kern H: Gastrointestinal failure score in critically ill patients: A prospective observational study. Crit Care. 12:R902008. View Article : Google Scholar : PubMed/NCBI
20	Wang G, Wen J, Wilbur RR, Wen P, Zhou SF and Xiao X: The effect of somatostatin, ulinastatin and Salvia miltiorrhiza on severe acute pancreatitis treatment. Am J Med Sci. 346:371–376. 2013. View Article : Google Scholar : PubMed/NCBI
21	Yoo YW, Cha SW, Kim A, Na SY, Lee YW, Kim SH, Lee HIe, Lee YJ, Yang HW and Jung SH: The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Gut Liver. 6:256–261. 2012. View Article : Google Scholar : PubMed/NCBI
22	Yin G, Hu G, Cang X, Yu G, Hu Y, Xing M, Chen C, Huang Y, Tang M, Zhao Y, et al: C-reactive protein: Rethinking its role in evaluating the severity of hyperlipidemic acute pancreatitis. Pancreas. 43:1323–1328. 2014. View Article : Google Scholar : PubMed/NCBI
23	Mroczko B, Groblewska M, Gryko M, Kedra B and Szmitkowski M: Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J Clin Lab Anal. 24:256–261. 2010. View Article : Google Scholar : PubMed/NCBI
24	Schütte K and Malfertheiner P: Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol. 22:75–90. 2008. View Article : Google Scholar : PubMed/NCBI
25	Zhang C, Wang Y, Fu W, Zhang W, Wang T and Qin H: A Meta-analysis on the effect of ulinastatin on serum levels of C-reactive protein, interleukin 6, and tumor necrosis factor alpha in Asian patients with acute pancreatitis. Genet Test Mol Biomarkers. 20:118–124. 2016. View Article : Google Scholar : PubMed/NCBI
26	Vermeire S, Van Assche G and Rutgeerts P: The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol. 2:580–586. 2005. View Article : Google Scholar : PubMed/NCBI
27	Cardoso FS, Ricardo L, Gondar P, Deus JR and Horta D: C-reactive protein may influence decisively the prescription of prophylactic antibiotics in acute pancreatitis: A population-based cohort study. Pancreas. 44:404–408. 2015.PubMed/NCBI
28	Wang X, Zhuang X, Wei R, Wang C, Xue X and Mao L: Protective effects of Acanthopanax vs. Ulinastatin against severe acute pancreatitis-induced brain injury in rats. Int Immunopharmacol. 24:285–298. 2015. View Article : Google Scholar : PubMed/NCBI
29	Shen Y, Cui N, Miao B and Zhao E: Immune dysregulation in patients with severe acute pancreatitis. Inflammation. 34:36–42. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wang G, Liu Y, Zhou SF, Qiu P, Xu L, Wen P, Wen J and Xiao X: Effect of Somatostatin, Ulinastatin and gabexate on the treatment of severe acute pancreatitis. Am J Med Sci. 351:506–512. 2016. View Article : Google Scholar : PubMed/NCBI
31	Reinisch W, Wang Y, Oddens BJ and Link R: C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: A post-hoc analysis from ACCENT I. Aliment Pharmacol Ther. 35:568–576. 2012. View Article : Google Scholar : PubMed/NCBI
32	Muddana V, Whitcomb DC, Khalid A, Slivka A and Papachristou GI: Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am J Gastroenterol. 104:164–170. 2009. View Article : Google Scholar : PubMed/NCBI
33	Chen Y, Zhang ZW, Wang B, Yin WH, Zuo YY, Kang Y and Liu J: Relationship between early serum albumin variation and prognosis in patients with severe acute pancreatitis treated in ICU. Sichuan Da Xue Xue Bao Yi Xue Ban. 44:237–241. 2013.(In Chinese). PubMed/NCBI